Related Experiment Video
Updated: Jul 4, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
A suppressive role of mitogen inducible gene-2 in mesenchymal cancer cell invasion
1707B Scaife Hall, Department of Pathology, University of Pittsburgh, 3550 Terrace Street, Pittsburgh, PA 15261, USA.
Abstract:
Cancer cell invasion of extracellular matrix (ECM) is essential for dissemination of cancer cells and metastasis. In this study, we have investigated the role of mitogen inducible gene-2 (Mig-2, also known as kindlin-2), a focal adhesion protein whose expression is altered in several types of human cancers, in mesenchymal cancer cell invasion. Mig-2 is abundantly expressed in SK-LMS-1 leiomyosarcoma cells. The level of Mig-2, however, is considerably lower in more invasive HT-1080 fibrosarcoma cells. Overexpression of Mig-2 in HT-1080 and SK-LMS-1 cells substantially reduced their ability to invade ECM in an in vitro Matrigel invasion assay. Conversely, knockdown of Mig-2 markedly increased the invasiveness of these cells. Consistent with a suppressive role in mesenchymal cancer cell invasion, Mig-2 inhibits urokinase-type plasminogen activator (uPA) secretion and pericellular proteolysis. Overexpression of Mig-2 increased uPA accumulation at the intracellular face of cell-ECM adhesions and reduced the level of secreted uPA. Conversely, knockdown of Mig-2 reduced uPA accumulation at the intracellular face of cell-ECM adhesions and increased uPA secretion. Our results reveal an important role of Mig-2 in suppression of mesenchymal cancer cell invasion and shed new light on how altered Mig-2 expression could influence cancer cell invasion.
Insights
Mitogen inducible gene-2 (Mig-2) suppresses mesenchymal cancer cell invasion by inhibiting urokinase-type plasminogen activator (uPA) secretion. Lower Mig-2 levels correlate with increased cancer cell invasiveness and metastasis potential.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Cancer cell invasion of the extracellular matrix (ECM) is a critical step in metastasis.
- Focal adhesion protein Mig-2 (kindlin-2) expression is altered in human cancers.
- The specific role of Mig-2 in mesenchymal cancer cell invasion remains unclear.
Purpose of the Study:
- To investigate the role of Mig-2 in mesenchymal cancer cell invasion.
- To determine the mechanism by which Mig-2 influences cancer cell invasiveness.
Main Methods:
- Investigated Mig-2 expression in SK-LMS-1 and HT-1080 cancer cell lines.
- Utilized in vitro Matrigel invasion assays to assess cell invasiveness.
- Examined the effect of Mig-2 overexpression and knockdown on urokinase-type plasminogen activator (uPA) secretion and localization.
Main Results:
- Mig-2 expression was inversely correlated with invasiveness; high in SK-LMS-1, low in HT-1080 cells.
- Overexpression of Mig-2 reduced ECM invasion, while Mig-2 knockdown increased invasiveness.
- Mig-2 inhibited uPA secretion and pericellular proteolysis by promoting uPA intracellular accumulation.
Conclusions:
- Mig-2 acts as a suppressor of mesenchymal cancer cell invasion.
- Altered Mig-2 expression influences cancer cell dissemination and metastasis.
- Mig-2's mechanism involves regulating uPA secretion and activity at cell-ECM adhesions.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction. It is...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
